Psychiatr. praxi. 2025;26(2):88-92 | DOI: 10.36290/psy.2025.016

The effect of transcranial magnetic stimulation on cognitive functions in patients with depression

Mgr. Markéta Kubinová1, doc. MUDr. Lucie Kališová, Ph.D.1, 2
1 1. lékařská fakulta Univerzity Karlovy, Praha
2 Psychiatrické oddělení Ústřední vojenské nemocnice v Praze

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive biological treatment method in many psychiatric, neurological, and otolaryngological indications. In psychiatry, rTMS proved its treatment effect mainly in the treatment of depression. rTMS is a well-tolerated treatment method, and side effects occur with proper indication and preparation rarely. This review brings comprehensive information about the impact of rTMS on cognitive performance in patients with depression. Results conclude that rTMS does not impair cognitive functions and, on the other hand, has a potential for improvement of cognition. This article confirms the safety of rTMS on cognitive function in patients with depression.

Keywords: transcranial magnetic stimulation, cognitive function, depression.

Accepted: June 9, 2025; Published: July 4, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kubinová M, Kališová L. The effect of transcranial magnetic stimulation on cognitive functions in patients with depression. Psychiatr. praxi. 2025;26(2):88-92. doi: 10.36290/psy.2025.016.
Download citation

References

  1. . Ustohal L. Repetitivní transkraniální magnetická stimulace v léčbě deprese. Psychiatrie pro Praxi. 2010;11(3):117-121.
  2. . Klírová M. Neinvazivnî mozková stimulace v psychiatrii: Od experimentálnîho výzkumu ke klinické aplikaci. Praha: Maxdorf, 2022. 102 s.
  3. . Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. The Lancet [online]. 1985; 325(8437):1106-1107. Go to original source... Go to PubMed...
  4. . Geurge MS, Wassermann EM, Williams WA, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. NeuroReport [online]. 1995;6(14), 1853-1856. doi:10.1097/00001756-199510020-00008. Go to original source... Go to PubMed...
  5. . Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clin Neurophysiol. 2020 Feb;131(2):474-528. doi: 10.1016/j.clinph.2019. 11. 002. Go to original source...
  6. . Klírová M, Buday J, Novák T. Repetitivní transkraniální magnetická stimulace (rTMS)Doporučené postupy psychiatrické péče 2022. Psychiatrická společnost ČLS JEP. Available from: https://postupy-pece.psychiatrie.cz/images/pdf/2022_rTMS.pdf.
  7. . Brunelin J, Jalenques I, Trojak B, et al. The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT. Brain Stimulation. 2014; 7(6):855-863. Go to original source... Go to PubMed...
  8. . Hyde J, Carr H, Kelley N, et al. Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials. Molecular psychiatry. 2022; 27(6):2709-2719. Go to original source... Go to PubMed...
  9. . Miron JP, Jodoin VD, Lespérance P, et al. Repetitive transcranial magnetic stimulation for major depressive disorder: basic principles and future directions. Ther Adv Psychopharmacol. 2021 Sep 23;11:20451253211042696. doi: 10.1177/20451253211042696. Go to original source... Go to PubMed...
  10. . Brunoni AR, Chaimani A, Moffa AH, et al. Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis. JAMA Psychiatry. 2017;74:143-52. Go to original source... Go to PubMed...
  11. . George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. Am J Psychiatry. 2011;168:356-64. Go to original source... Go to PubMed...
  12. . Dardenne A, Baeken C, Crunelle CL, et al. Accelerated HF-rTMS in the elderly depressed: A feasibility study. Brain Stimul. 2018;11:247-8. Go to original source... Go to PubMed...
  13. . Ustohal L. Transkraniálnî magnetická stimulace a psychofarmaka. Psychiatrie. 2021, 25(3):126-29.
  14. . Rossi S, Antal A, Bestmann S, et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clin Neurophysiol. 2021 Jan;132(1):269-306. doi: 10.1016/j.clinph.2020. 10. 003. Go to original source...
  15. . Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section [online]. 1998;108(1):1-16 [cit. 2023-08-21]. Available from: doi:10.1016/S0168-5597(97)00096-8. Go to original source... Go to PubMed...
  16. . Corlier J, Burnette E, Wilson AC, et al. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control. Journal of affective disorders. 2020;265:272-277. Go to original source... Go to PubMed...
  17. . Chen Y, Li X, Wang L, et al. Effects of Repetitive Transcranial Magnetic Stimulation on Cognitive Function in Patients With Stress-Related Depression: A Randomized Double-Blind fMRI and 1H-MRS Study. Frontiers in Neurology. 2022; 13:844606. doi: 10.3389/fneur.2022.844606. Go to original source... Go to PubMed...
  18. . Asgharian AF, Abbaszade S, Derakhshani H, et al. Unilateral vs. bilateral DLPFC rTMS: comparative effects on depression, visual-spatial memory, inhibitory control and cognitive flexibility in major depressive disorder. Frontiers in Psychiatry. 2024; 15:1400414. doi:10.3389/fpsyt.2024.1400414. Go to original source... Go to PubMed...
  19. . Asgharian AF, Vaghef L. The effectiveness of high-frequency left DLPFC-rTMS on depression, response inhibition, and cognitive flexibility in female subjects with major depressive disorder. Journal of Psychiatric Research. 2022;149:287-292,2022. doi: 10.1016/j.jpsychires.2022. 01. 025. Go to original source...
  20. . Tong J, Zhang J, Jin Y, et al. Impact of repetitive transcranial magnetic stimulation (rTMS) on theory of mind and executive function in major depressive disorder and its correlation with brain-derived neurotrophic factor (BDNF): a randomized, double-blind, sham-controlled trial. Brain Sciences. 2021;11(6):765. doi: 10.3390/brainsci11060765. Go to original source... Go to PubMed...
  21. . Yildiz T, Oğuzhanoğlu NK, Topak OZ. Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study.Turkish Journal of Medical Sciences. 2023; 53(1)253-263. doi: 10.55730/1300-0144.5580. Go to original source... Go to PubMed...
  22. . Tateishi H, Mizoguchi Y, Kawaguchi A, et al. Changes in interleukin-1 beta induced by rTMS are significantly correlated with partial improvement of cognitive dysfunction in treatment-resistant depression: A pilot study. Psychiatry research. 2020 289:112995. doi: 10.1016/j.psychres.2020.112995. Go to original source... Go to PubMed...
  23. . Serafini G, Pompili, M, Belvederi MM, et al. The effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression. A systematic review. Neuropsychobiology. 2015; 71(3):125-139. Go to original source... Go to PubMed...
  24. . Martin DM, McClintock SM, Forster JJ, et al. Cognitive enhancing effects of rTMS administered to the prefrontal cortex in patients with depression: A systematic review and meta-analysis of individual task effects. Depression and anxiety. 2017;34(11):1029-1039. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.